Ƶ Human Induced Pluripotent Stem Cell (iPSC) Program
To advance translational and precision medicine research, the CVRC has established the Human Induced Pluripotent Stem Cell (iPSC) Program funded by the Advancing a Healthier Wisconsin Endowment (2019-2022) and the Ƶ Dean’s Program Development funds (2023-Present). Over 600 square feet within the center provides quality iPSCs from a matching biorepository, consisting of somatic cells obtained from patient’s representative of the region/community in which we serve. The core is brought to you by a collaboration between the Cardiovascular Research Center, Department of Physiology and the Department of Pediatrics, Cardiology.
The Core Offers:
- Human iPSC reprogramming from peripheral blood monocytes or fibroblasts (skin biopsy)
- Human iPSC cell line differentiation services into endothelial cells, cardiomyocytes, or vascular smooth muscle cells
- iPSC CRISPR gene knockout/knock-in or single nucleotide editing
- Premade cell products from bank or select validated external sources
- Methodological development (e.g., organoids, additional cell types)
- Training for laboratory staff and pre/post-doctoral trainees on these methodologies
- And more!
iPSC Staff



For services, contact